SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Van der Heijde D, van der Linden S, Bellamy N, Calin C, Dougados M, Khan MA. Which domains should be included in a core set for endpoints in ankylosing spondylitis: introduction to the ankylosing spondylitis module of OMERACT IV. J Rheumatol 1999; 26: 9457.
  • 2
    Van der Heijde D, Calin A, Dougados M, Khan MA, van der Linden S, Bellamy N on behalf of the ASAS Working Group. Selection of instruments in the core set for DC-ART, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis: progress report of the ASAS Working Group. J Rheumatol 1999; 26: 9514.
  • 3
    Calin A, Garrett S, Whitelock H, Kennedy LG, O'Hea J, Mallorie P, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994; 21: 22815.
  • 4
    Dougados M, Gueguen A, Nakache JP, Nguyen M, Mery C, Amor B. Evaluation of a functional index and an articular index in ankylosing spondylitis. J Rheumatol 1988; 15: 3027.
  • 5
    Brandt J, Haibel H, Cornely D, Golder W, Gonzalez J, Reddig J, et al. Successful treatment of active ankylosing spondylitis with the anti tumor necrosis factor alpha monoclonal antibody infliximab. Arthritis Rheum 2000; 43: 134652.
  • 6
    Maksymowych WP, Jhangry GS, Leclercq S, Skeith K, Yan A, Russell A. An open study of pamidronate in the treatment of refractory ankylosing spondylitis. J Rheumatol 1998; 25: 7147.
  • 7
    Jones SD, Koh WH, Steiner A, Garrett SL, Calin A. Fatigue in ankylosing spondylitis: its prevalence and relationships with activity, sleep, and other factors. J Rheumatol 1996; 23: 48790.
  • 8
    Koh WH, Paude I, Samuels A, Jones SD, Calin A. Low dose amiltriptyline in ankylosing spondylitis: a short term, double blind, placebo controlled study. J Rheumatol 1997; 24: 215861.
  • 9
    Moncur C, Cannon GW, Shaw M, Willardson D, Clegg DO. Inter-observer reliability of the Spondylitis Functional Index instruments for assessing spondylarthropathies. Arthritis Care Res 1996; 9: 1828.
  • 10
    Calin A, Nakache J-P, Gueguer A, Zeidler H, Mielants H, Dougados M. Outcome variables in ankylosing spondylitis: evaluation of their relevance and discriminant capacity. J Rheumatol 1999; 26: 9759.
  • 11
    Jones SD, Steiner A, Garrett SL, Calin A. The Bath Ankylosing Spondylitis Patient Global Score. Br J Rheumatol 1996; 35: 6671.
  • 12
    Averns HL, Oxtoby J, Taylor HG, Jones PW, Dziedzic K, Dawes PT. Smoking and outcome in ankylosing spondylitis. Scand J Rheumatol 1996; 25: 13842.
  • 13
    Van der Heijde D, Bellamy N, Calin A, Dougados M, Khan MA, van der Linden S on behalf of the Assessment in Ankylosing Spondylitis Working Group. Preliminary core set for endpoints in ankylosing spondylitis. J Rheumatol 1997; 24: 22259.
  • 14
    Ward MM. Health-related quality of life in ankylosing spondylitis: a survey of 175 patients. Arthritis Care Res 1999; 12: 24755.
  • 15
    Ringsdal VS, Helin P: Ankylosing spondylitis-education, employment and invalidity. Dan Med Bull 1991; 38: 2824.
  • 16
    Van der Linden SM, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum 1984; 27: 3618.
  • 17
    Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994; 21: 228691.
  • 18
    Jenkinson TR, Mallorie PA, Whitelock HC, Kennedy LG, Garrett SL, Calin A. Defining spinal mobility in ankylosing spondylitis (AS): the Bath AS Metrology Index. J Rheumatol 1994; 21: 16948.
  • 19
    Jones SD, Porter J, Garrett SL, Kennedy LG, Whitelock H, Calin A. A new scoring system for the Bath Ankylosing Spondylitis Metrology Index (BASMI) [letter]. J Rheumatol 1995; 22: 1609.
  • 20
    Alonso J, Prieto L, Antó JM. La versión española del SF-36 Health Survey (cuestionario de salud SF-36): un instrumento para la medida de los resultados clínicos. Med Clin (Barc) 1995; 104: 7716.
  • 21
    Badía X, Roset M, Montserrat S, Herdman M, Segura A. The Spanish version of EuroQol: a description and its applications: European Quality of Life scales. Med Clin (Barc) 1999; 112 Suppl 1: 7985.
  • 22
    Band DA, Jones SD, Kennedy LG, Garrett SL, Porter J, Gay L, et al. Which patients with ankylosing spondylitis derive most benefit from an inpatient management program? J Rheumatol 1997; 24: 23814.
  • 23
    Jones SD, Calin A, Steiner A. An update of the Bath Ankylosing Spondylitis Activity and Functional indices (BASDAI, BASFI): excellent Cronbach's alpha scores [letter]. J Rheumatol 1996; 23: 407.